BP lowering and cardiovascular risk reduction

2021 ◽  
pp. dtb-2021-000065
Keyword(s):  
Blood Pressure ◽  
Meta Analysis ◽  
Blood Pressure Lowering ◽  
Primary And Secondary Prevention ◽  
Cardiovascular Risk Reduction ◽  
Level Data ◽  
Pressure Lowering ◽  
Individual Participant ◽  
Different Levels ◽  
Prevention Of Cardiovascular Disease

AbstractOverview of: The Blood Pressure Lowering Treatment Triallists’ Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet 2021;397:1625–36.

scholarly journals EFFECTS OF BLOOD PRESSURE-LOWERING ON CANCER RISK: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF 300,000 PARTICIPANTS

2021 ◽  
Vol 39 (Supplement 1) ◽  
pp. e7
Author(s):  
Emma Copland ◽  
Dexter Canoy ◽  
Milad Nazarzadeh ◽  
Zeinab Bidel ◽  
Mark Woodward ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Cancer Risk ◽  
Meta Analysis ◽  
Individual Participant Data ◽  
Blood Pressure Lowering ◽  
Pressure Lowering ◽  
Individual Participant

scholarly journals Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis

The Lancet ◽  
2021 ◽  
Vol 398 (10313) ◽  
pp. 1803-1810 ◽  
Author(s):  
Milad Nazarzadeh ◽  
Zeinab Bidel ◽  
Dexter Canoy ◽  
Emma Copland ◽  
Malgorzata Wamil ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Meta Analysis ◽  
Individual Participant Data ◽  
Blood Pressure Lowering ◽  
Onset Type ◽  
Pressure Lowering ◽  
Individual Participant ◽  
New Onset
Sign in / Sign up

Export Citation Format

Share Document